PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31835640-1	2019	Vortioxetine is a novel, multimodal antidepressant with unique targets, including the inhibition of the serotonin transporter (SET), of serotonin 5-HT3 (5-HT3R), and of 5-HT7 (5-HT7R) receptors and partial agonism to serotonin 5-HT1A (5-HT1AR) receptors in humans.	Vortioxetine	0-12	5-hydroxytryptamine receptor 7	Homo sapiens	169-174	
31835640-1	2019	Vortioxetine is a novel, multimodal antidepressant with unique targets, including the inhibition of the serotonin transporter (SET), of serotonin 5-HT3 (5-HT3R), and of 5-HT7 (5-HT7R) receptors and partial agonism to serotonin 5-HT1A (5-HT1AR) receptors in humans.	Vortioxetine	0-12	5-hydroxytryptamine receptor 7	Homo sapiens	176-182	
31835640-2	2019	Vortioxetine has a lower affinity to 5-HT1AR and 5-HT7R in rats compared with humans, but several behavior studies have demonstrated its powerful antidepressant-like actions.	Vortioxetine	0-12	5-hydroxytryptamine receptor 7	Homo sapiens	49-55